Remove Blogging Remove Development Remove San Diego Remove Venture Capital
article thumbnail

San Diego Roundup: Qualcomm, Philter, Stella Labs, VC Funding & More

Xconomy

Let’s catch up with the latest tech news in San Diego. —San Diego’s AON Devices was among 10 startups selected to compete at a recent pitch competition hosted by the corporate venture capital arm of Qualcomm (NASDAQ: QCOM ).

article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns

Xconomy

Ciara Kennedy, CEO of clinical-stage antifungal therapy developer Amplyx, is facing a slowdown in trial enrollment as hospitals focus on handling the influx of pandemic patients. The program, originally slated to take.

San Diego 120
article thumbnail

San Diego VC Funding at $426.6M in Third Quarter; Plus Top 10 Deals

Xconomy

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. Altogether, venture firms invested.

article thumbnail

Dutch Biotech Raises $19M to Develop Psoriasis Drug Near San Diego

Xconomy

Escalier Biosciences BV, a biotech developing drugs for psoriasis and other autoimmune disorders, said it has raised $19 million in a Series B financing led by Forbion, a Dutch life sciences investor. The Dutch biotech and its Encinitas subsidiary were both founded in 2016, but the. Read more » Reprints | Share:

article thumbnail

Viracta, Neurelis & More: The Latest in San Diego Biotech

Xconomy

Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy. Let’s get caught up with the latest life sciences news in San Diego. The San Diego biotech is developing therapies for cancers related to the Epstein-Barr virus.

article thumbnail

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals

Xconomy

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego. But the San Diego data was off.